Login / Signup
Vitya Chandika
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Radiation Therapy
Respiratory Syndrome Coronavirus
Hodgkin Lymphoma
Lipopolysaccharide Induced
Top Venues
International medical case reports journal
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Wulyo Rajabto
,
Vitya Chandika
,
Agnes Stephanie Harahap
,
Maria Francisca Ham
The Role of Brentuximab Vedotin (BV) as Second-Line Treatment of Refractory Classical Hodgkin Lymphoma (cHL) in the Era of Pandemic COVID-19.
International medical case reports journal
15 (2022)